Effects of edaravone on amyloid-β precursor protein processing in SY5Y-APP695 cells

Neurotoxicity Research

Volumn 24, Issue 2, 2013, Pages 139-147

  Shen, Yue E ^a   Wang, Yan ^a   Yu, Gui Chun ^a   Liu, Chao ^a   Zhang, Zhen Yu ^a   Zhang, Li Ming ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Amyloid beta; APP processing; Edaravone

Indexed keywords

ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; INSULINASE; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA; NORPHENAZONE;

ARTICLE; CELL STRAIN; CELL STRAIN APP695; CELL STRAIN SH SY5Y; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTATION; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SYNTHESIS REGULATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANTIPYRINE; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICAL SCAVENGERS; HUMANS; PROTEIN MODIFICATION, TRANSLATIONAL; TREATMENT OUTCOME;

EID: 84879799133     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-012-9370-3     Document Type: Article

References (61)

1. Abe K, Yuki S, Kogure K (1988) Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19(4):480-485
2. Arii K, Kumon Y, Ikeda Y, Suehiro T, Hashimoto K (2006) Edaravone inhibits the disease activity in rheumatoid arthritis. J Clin Pharm Ther 31(2):197-199. doi: 10.1111/j.1365-2710.2006.00722.x
3. Austin SA, Santhanam AV, Katusic ZS (2010) Endothelial nitric oxide modulates expression and processing of amyloid precursor protein. Circ Res 107(12):1498-1502. doi: 10.1161/CIRCRESAHA.110.233080
4. Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, Rock CL, Pruitt MA, Yang F, Hudspeth B, Hu S, Faull KF, Teter B, Cole GM, Frautschy SA (2008) Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther 326(1):196-208. doi: 10.1124/jpet.108.137455
5. Cardoso SM, Proenca MT, Santos S, Santana I, Oliveira CR (2004) Cytochrome c oxidase is decreased in Alzheimer's disease platelets. Neurobiol Aging 25(1):105-110
6. Chauhan NB, Sandoval J (2007) Amelioration of early cognitive deficits by aged garlic extract in Alzheimer's transgenic mice. Phytother Res 21(7):629-640
7. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P et al (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer' disease increases β-protein production. Nature 360(6405):672-674
8. Dumont M, Ho DJ, Calingasan NY, Xu H, Gibson G, Beal MF (2009) Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition. Free Radic Biol Med 47(7):1019-1027. doi: 10.1016/j.freeradbiomed.2009.07.008
9. Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ (2007) Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102(4):1095-1104. doi: 10.1111/j.1471-4159.2007.04613.x
10. Gibson GE, Blass JP, Beal MF, Bunik V (2005) The alpha-ketoglutarate- dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration. Mol Neurobiol 31(1-3):43-63. doi: 10.1385/MN:31:1-3:043
11. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297(5580):353-356. doi: 10.1126/science.1072994
12. Heo HJ, Kim DO, Choi SJ, Shin DH, Lee CY (2004) Potent inhibitory effect of flavonoids in Scutellaria baicalensis on amyloid beta protein-induced neurotoxicity. J Agric Food Chem 52(13):4128-4132
13. Houkin K, Nakayama N, Kamada K, Noujou T, Abe H, Kashiwaba T (1998) Neuroprotective effect of the free radical scavenger MCI-186 in patients with cerebral infarction: clinical evaluation using magnetic resonance imaging and spectroscopy. J Stroke Cerebrovasc Dis 7(5):315-322
14. Inokuchi Y, Imai S, Nakajima Y, Shimazawa M, Aihara M, Araie M, Hara H (2009) Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo. J Pharmacol Exp Ther 329(2):687-698
15. Isahaya K, Yamada K, Yamatoku M, Sakurai K, Takaishi S, Kato B, Hirayama T, Hasegawa Y (2012) Effects of edaravone, a free radical scavenger, on serum levels of inflammatory biomarkers in acute brain infarction. J Stroke Cerebrovasc Dis 21(2):102-107
16. Ishikawa A, Yoshida H, Metoki N, Toki T, Imaizumi T, Matsumiya T, Yamashita K, Taima K, Satoh K (2007) Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia. Neurosci Res 59(4):406-412. doi: 10.1016/j.neures.2007.08.008
17. Jamsa A, Belda O, Edlund M, Lindstrom E (2011) BACE-1 inhibition prevents the gamma-secretase inhibitor evoked Abeta rise in human neuroblastoma SH-SY5Y cells. J Biomed Sci 18:76. doi: 10.1186/1423-0127-18-76
18. Kamida T, Fujiki M, Ooba H, Anan M, Abe T, Kobayashi H (2009) Neuroprotective effects of edaravone, a free radical scavenger, on the rat hippocampus after pilocarpine-induced status epilepticus. Seizure 18(1):71-75. doi: 10.1016/j.seizure.2008.06.012
19. Kaur C, Ling EA (2008) Antioxidants and neuroprotection in the adult and developing central nervous system. Curr Med Chem 15(29):3068-3080
20. Kim J, Lee HJ, Lee KW (2010) Naturally occurring phytochemicals for the prevention of Alzheimer's disease. J Neurochem 112(6):1415-1430. doi: 10.1111/j.1471-4159.2009.06562.x
21. Koizumi T, Tanaka H, Sakaki S, Shimazaki S (2006) The therapeutic efficacy of edaravone in extensively burned rats. Arch Surg 141(10):992-995. doi: 10.1001/archsurg.141.10.992
22. Kojru E, Gimpl G, Lammich S, März W, Fahrenholz F (2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10. PNAS USA 98(10):5815-5820
23. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27(4):796-807. doi: 10.1523/JNEUROSCI.3501-06. 2007
24. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95(11):6448-6453
25. Leuchtenberger S, Kummer MP, Kukar T, Czirr E, Teusch N, Sagi SA, Berdeaux R, Pietrzik CU, Ladd TB, Golde TE, Koo EH, Weggen S (2006) Inhibitors of Rho-kinase modulate amyloid-beta (Abeta) secretion but lack selectivity for Abeta42. J Neurochem 96(2):355-365. doi: 10.1111/j.1471-4159.2005.03553.x
26. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21(21):8370-8377
27. Ma QL, Lim GP, Harris-White ME, Yang F, Ambegaokar SS, Ubeda OJ, Glabe CG, Teter B, Frautschy SA, Cole GM (2006) Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro. J Neurosci Res 83(3):374-384. doi: 10.1002/jnr.20734
28. Malaplate-Armand C, Florent-Bechard S, Youssef I, Koziel V, Sponne I, Kriem B, Leininger-Muller B, Olivier JL, Oster T, Pillot T (2006) Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway. Neurobiol Dis 23(1):178-189. doi: 10.1016/j.nbd.2006.02.010
29. Mao YF, Yan N, Xu H, Sun JH, Xiong YC, Deng XM (2009) Edaravone, a free radical scavenger, is effective on neuropathic pain in rats. Brain Res 1248:68-75. doi: 10.1016/j.brainres.2008.10.073
30. Mikawa K, Akamatsu H, Nishina K, Obara H, Niwa Y (2005) Effects of edaravone on human neutrophil function. Acta Anaesthesiol Scand 49(3):385-389. doi: 10.1111/j.1399-6576.2005.00610.x
31. Mishina M, Komaba Y, Kobayashi S, Tanaka N, Kominami S, Fukuchi T, Mizunari T, Hamamoto M, Teramoto A, Katayama Y (2005) Efficacy of edaravone, a free radical scavenger, for the treatment of acute lacunar infarction. Neurol Med Chir (Tokyo) 45(7):344-348; discussion 348
32. Nalivaeva NN, Beckett C, Belyaev ND, Turner AJ (2012) Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease? J Neurochem 120(Suppl. 1):167-185
33. Nishi H, Watanabe T, Sakurai H, Yuki S, Ishibashi A (1989) Effect of MCI-186 on brain edema in rats. Stroke 20(9):1236-1240
34. Nishinaka Y, Mori H, Endo N, Miyoshi T, Yamashita K, Adachi S, Arai T (2010) Edaravone directly reacts with singlet oxygen and protects cells from attack. Life Sci 86(21-22):808-813
35. Otani H, Togashi H, Jesmin S, Sakuma I, Yamaguchi T, Matsumoto M, Kakehata H, Yoshioka M (2005) Temporal effects of edaravone, a free radical scavenger, on transient ischemia-induced neuronal dysfunction in the rat hippocampus. Eur J Pharmacol 512(2-3):129-137. doi: 10.1016/j.ejphar.2005.01.050
36. Pickrell AM, Fukui H, Moraes CT (2009) The role of cytochrome c oxidase deficiency in ROS and amyloid plaque formation. J Bioenerg Biomembr 41(5):453-456. doi: 10.1007/s10863-009-9245-3
37. Recuero M, Munoz T, Aldudo J, Subias M, Bullido MJ, Valdivieso F (2010) A free radical-generating system regulates APP metabolism/processing. FEBS Lett 584(22):4611-4618. doi: 10.1016/j.febslet.2010.10.028
38. Saini AK, Kumar HSA, Sharma SS (2007) Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy. Eur J Pharmacol 568(1-3):164-172. doi: 10.1016/j.ejphar.2007.04.016
39. Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81(2):741-766
40. Smith RA, Murphy MP (2010) Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci 1201:96-103. doi: 10.1111/j.1749-6632.2010.05627.x
41. Sonnen JA, Breitner JC, Lovell MA, Markesbery WR, Quinn JF, Montine TJ (2008) Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. Free Radic Biol Med 45(3):219-230. doi: 10.1016/j.freeradbiomed.2008.04.022
42. Sorbi S, Bird ED, Blass JP (1983) Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol 13(1):72-78. doi: 10.1002/ana.410130116
43. Spindler M, Beal MF, Henchcliffe C (2009) Coenzyme Q10 effects in neurodegenerative disease. Neuropsychiatr Dis Treat 5:597-610
44. Suzuki K, Kazui T, Terada H, Umemura K, Ikeda Y, Bashar AH, Yamashita K, Washiyama N, Suzuki T, Ohkura K, Yasuike J (2005) Experimental study on the protective effects of edaravone against ischemic spinal cord injury. J Thorac Cardiovasc Surg 130(6):1586-1592. doi: 10.1016/j.jtcvs.2005.08.049
45. Takahashi R (2009) Edaravone in ALS. Exp Neurol 217(2):235-236. doi: 10.1016/j.expneurol.2009.03.001
46. Taupin P (2010) A dual activity of ROS and oxidative stress on adult neurogenesis and Alzheimer's disease. Cent Nerv Syst Agents Med Chem 10(1):16-21
47. Tauskela JS (2007) MitoQ-a mitochondria-targeted antioxidant. IDrugs 10(6):399-412
48. Tillement L, Lecanu L, Papadopoulos V (2011) Alzheimer's disease: effects of beta-amyloid on mitochondria. Mitochondrion 11(1):13-21. doi: 10.1016/j.mito.2010.08.009
49. Wadsworth TL, Bishop JA, Pappu AS, Woltjer RL, Quinn JF (2008) Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease. J Alzheimers Dis 14(2):225-234
50. Wang YJ, Zhou HD, Zhou XF (2006) Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives. Drug Discov Today 11(19-20):931-938. doi: 10.1016/j.drudis.2006.08.004
51. Wang S, Wang R, Chen L, Bennett DA, Dickson DW, Wang DS (2010a) Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain. J Neurochem 115(1):47-57. doi: 10.1111/j.1471-4159.2010.06899.x
52. Wang X, Zheng W, Xie JW, Wang T, Wang SL, Teng WP, Wang ZY (2010b) Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model. Mol Neurodegener 5:46. doi: 10.1186/1750-1326-5-46
53. Watanabe T, Yuki S, Egawa M, Nishi H (1994) Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 268(3):1597-1604
54. Watanabe K, Morinaka Y, Iseki K, Watanabe T, Yuki S, Nishi H (2003) Structure-activity relationship of 3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone). Redox Rep 8(3):151-155. doi: 10.1179/135100003225001520
55. Watanabe T, Tahara M, Todo S (2008) The novel antioxidant edaravone: from bench to bedside. Cardiovasc Ther 26(2):101-114. doi: 10.1111/j.1527-3466.2008. 00041.x
56. Woltjer RL, McMahan W, Milatovic D, Kjerulf JD, Shie FS, Rung LG, Montine KS, Montine TJ (2007) Effects of chemical chaperones on oxidative stress and detergent-insoluble species formation following conditional expression of amyloid precursor protein carboxy-terminal fragment. Neurobiol Dis 25(2):427-437. doi: 10.1016/j.nbd.2006.10.003
57. Wu G, Sankaranarayanan S, Hsieh SH, Simon AJ, Savage MJ (2011) Decrease in brain soluble amyloid precursor protein beta (sAPPbeta) in Alzheimer's disease cortex. J Neurosci Res 89(6):822-832. doi: 10.1002/jnr.22618
58. Xiao B, Bi FF, Hu YQ, Tian FF, Wu ZG, Mujlli HM, Ding L, Zhou XF (2007) Edaravone neuroprotection effected by suppressing the gene expression of the Fas signal pathway following transient focal ischemia in rats. Neurotox Res 12(3):155-162
59. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280(7):5892-5901. doi: 10.1074/jbc.M404751200
60. Yoshida H, Yanai H, Namiki Y, Fukatsu-Sasaki K, Furutani N, Tada N (2006) Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev 12(1):9-20. doi: 10.1111/j.1527-3458.2006. 00009.x
61. Zhang L, Fiala M, Cashman J, Sayre J, Espinosa A, Mahanian M, Zaghi J, Badmaev V, Graves MC, Bernard G, Rosenthal M (2006) Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. J Alzheimers Dis 10(1):1-7 Heilongjiang Province Bureau